[HTML][HTML] Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
R Ezzat, M Eltabbakh, M El Kassas - World Journal of …, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the sixth most common primary malignancy worldwide,
and the third most common cause of death among cancers worldwide. HCC occurs in …
and the third most common cause of death among cancers worldwide. HCC occurs in …
Hepatocellular carcinoma recurrence after hepatitis C virus therapy with direct-acting antivirals. A systematic review and meta-analysis
L Frazzoni, U Sikandar, F Metelli, S Sadalla… - Journal of clinical …, 2021 - mdpi.com
Background: Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality
among patients with cirrhosis. The risk of HCC recurrence after a complete response among …
among patients with cirrhosis. The risk of HCC recurrence after a complete response among …
[HTML][HTML] Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
Since direct-acting antiviral agents (DAAs) have been introduced into hepatitis C virus
treatment, the sustained viral response (SVR) rate has significantly increased to more than …
treatment, the sustained viral response (SVR) rate has significantly increased to more than …
Safety, efficacy and cost of two direct‐acting antiviral regimens: A comparative study in chronic hepatitis C Egyptian patients
AH Ibrahim Mohammed Ebid… - Journal of Clinical …, 2020 - Wiley Online Library
What is known and objective Direct‐acting antivirals (DAAs) have become the most widely
used treatment of chronic hepatitis C infection. Comparative studies on DAAs regimens …
used treatment of chronic hepatitis C infection. Comparative studies on DAAs regimens …
Assessment of Incidence of Hepatocellular Carcinoma among Hepatitis C Patients Who Achieved Sustained Virological Response with Direct Acting Antiviral Agents …
IM Ibrahim, ME Farghaly, A Embaby… - … Egyptian Journal of …, 2023 - ejhm.journals.ekb.eg
Background: In terms of cancer mortality rates, hepatocellular carcinoma (HCC) ranks third.
Direct-acting antiviral drugs (DAAs) had a profound impact on the treatment of hepatitis C …
Direct-acting antiviral drugs (DAAs) had a profound impact on the treatment of hepatitis C …
[PDF][PDF] The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon+ Ribavirin
ABSTRACT ÖZ Objectives: Directly-acting anti-viral agents for the treatment of hepatitis C
have been revolutionised. In the meantime, hepatitis C patients with sustained virologic …
have been revolutionised. In the meantime, hepatitis C patients with sustained virologic …
[PDF][PDF] A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs
MM Mousa, MAE El Dahshan, AAE Qasem… - Al-Azhar International …, 2020 - journals.ekb.eg
Background: infection with hepatitis c poses a global health problem that affect 200 million
chronically infected patients globally. infected patients with hepatitis c virus (HCV) run high …
chronically infected patients globally. infected patients with hepatitis c virus (HCV) run high …